Using CT to Check Lung Cancer Spread
Part of Cancer clinical trials.
This study uses a special type of CT scan (dual energy CT) to look at lung nodules that are 3 cm or smaller and have been confirmed as lung adenocarcinoma. The goal is to see if the scan can help tell how aggressive the cancer is, which may guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a lung nodule that is 3 cm or smaller.
- The nodule has been confirmed as lung adenocarcinoma by biopsy.
- You have no history of other cancers.
- You had a blood test for red blood cell count within the past week before the CT scan.
- You are not allergic to iodine contrast dye and can have the CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lung “biomarkers” (test results from your nodule/tissue) to better predict risk of cancer coming back and to guide long-term follow-up. It may help doctors choose the best surveillance plan after surgery or other treatment for early, potentially curable lung cancer.
This study looks at CT scans from people with early-stage lung cancer to see if we can predict if the cancer might have spread through the air spaces in the lung. It aims to help doctors decide on better treatment after surgery.
This trial tests a special PET/CT scan to spot early lung cancer by finding specific body processes linked to cancer. It compares scan results in people with lung nodules that are either cancer (lung adenocarcinoma) or likely benign.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This study is testing a new method to help tell whether a lung nodule is benign (non-cancerous) or malignant (cancerous). It is for people who already need a biopsy or surgery for their lung nodule.
Hear when a new Adenocarcinoma of Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.